Inhibikase Therapeutics, Inc. Share Price
Equities
IKT
US45719W2052
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.47 USD | -7.55% | -6.96% | +15.75% |
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 10.3M 859M |
---|---|---|---|---|---|
Net income 2024 * | -23M -1.92B | Net income 2025 * | -27M -2.25B | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-0.89
x | P/E ratio 2025 * |
-1.18
x | Employees | 9 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 86.15% |
Latest transcript on Inhibikase Therapeutics, Inc.
1 day | -7.55% | ||
1 week | -6.96% | ||
Current month | -31.94% | ||
1 month | -31.94% | ||
3 months | -53.33% | ||
6 months | +69.02% | ||
Current year | +15.75% |
Managers | Title | Age | Since |
---|---|---|---|
Milton Werner
FOU | Founder | 61 | 01/08/01 |
C. Warren Olanow
CTO | Chief Tech/Sci/R&D Officer | - | 04/21/04 |
Surendra Singh
COO | Chief Operating Officer | - | 01/14/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Dennis Berman
BRD | Director/Board Member | 73 | 01/19/01 |
Paul Grint
BRD | Director/Board Member | 66 | 22/20/22 |
Milton Werner
FOU | Founder | 61 | 01/08/01 |
Date | Price | Change | Volume |
---|---|---|---|
01/24/01 | 1.47 | -7.55% | 54 765 |
29/24/29 | 1.59 | -7.02% | 40,442 |
26/24/26 | 1.71 | -10.00% | 98,983 |
25/24/25 | 1.9 | +1.60% | 21,668 |
24/24/24 | 1.87 | +18.35% | 62,249 |
Delayed Quote Nasdaq, April 01, 2024 at 01:30 am IST
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+15.75% | 10.3M | |
+0.17% | 42.86B | |
+10.92% | 42.74B | |
+44.30% | 41.36B | |
-6.20% | 27.68B | |
+5.23% | 25.15B | |
-24.79% | 18.63B | |
+26.69% | 12.37B | |
-3.13% | 11.92B | |
+6.57% | 11.21B |
- Stock Market
- Equities
- IKT Stock